What was the result of the ACTIVE W trial?
The ACTIVE W trial found that warfarin reduced stroke risk compared with the dual antiplatelet regimen (RR reduction, 40%; 95% CI, 18 56; P=0.001) and no significant difference in risk of ACTIVE A compared the combination of clopidogrel and aspirin with aspirin alone.